• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS US CORP OPTEASE; FILTER, INTRAVASCULAR, CARDIOVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS US CORP OPTEASE; FILTER, INTRAVASCULAR, CARDIOVASCULAR Back to Search Results
Catalog Number 466F210AF
Medical Device Problem Code Migration (4003)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/09/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The device is available for analysis but has not yet been received.Additional information is pending and will be submitted within 30 days upon receipt.
 
Event or Problem Description
As reported, the 55 cm optease vena cava filter was pulled down to the iliac vein, and it was found that the filter had broken off in the patient's body, and it was recovered and re-released.After filter release was completed, an unknown pig contrast catheter was used to visualize the pulmonary artery, and when the catheter was withdrawn it passed through the inferior vena cava, the filter was pulled down to the iliac vein, and it was found that the filter had broken off in the patient's body, and it was recovered and re-released.There was no reported patient injury.The indication for filter insertion was deep vein thrombosis (dvt).The device was in situ for ten (10) minutes before retrieval was attempted.The access site was normal, and the retrieval access site was the femoral vein.Concomitant devices used during the retrieval attempt included an unknown guidewire and a snare.The vena cava was less than 30 mm in size and was not measured or estimated.The vessel was not calcified and had no acute bends or tortuosity.The product was stored and handled according to the instructions for use (ifu), and the device was prepped according to the ifu.There were no visible signs of device or package damage prior to use.The device is expected to be returned for evaluation.
 
Additional Manufacturer Narrative
As reported, the 55 cm optease vena cava filter was pulled down to the iliac vein, and it was found that the filter had broken off in the patient's body, and it was recovered and re-released.After filter release was completed, an unknown pigtail contrast catheter was used to visualize the pulmonary artery, and when the catheter was withdrawn it passed through the inferior vena cava, the filter was pulled down to the iliac vein, and it was found that the filter had broken off in the patient's body, and it was recovered and re-released.There was no reported patient injury.The indication for filter insertion was deep vein thrombosis (dvt).The device was in situ for ten (10) minutes before retrieval was attempted.The access site was normal, and the retrieval access site was the femoral vein.Concomitant devices used during the retrieval attempt included an unknown guidewire and a snare.The vena cava was less than 30 mm in size and was not measured or estimated.The vessel was not calcified and had no acute bends or tortuosity.The product was stored and handled according to the instructions for use (ifu), and the device was prepped according to the ifu.There were no visible signs of device or package damage prior to use.The product was not returned for analysis.A review of the manufacturing documentation associated with lot 18356215 presented no issues during the manufacturing process that can be related to the reported event.Based on the limited information provided, it is not possible to draw a conclusion about a clinical relationship between the device and the event.Without the return of the device for analysis, the reported customer complaint "filter migration embolization embolization-caudal" could not be confirmed.Without films of the reported event there is not enough information to draw a definitive clinical conclusion between the device and the reported event.Ivc filter migration is a known potential adverse event associated with all ivc filter implants and is listed in the ifu as such.Possible causes for filter migration includes mega cava (ivc diameter >28 mm), wire entrapment during central venous catheter placement, ¿sail¿ effect (cranial migration) of large clot burden within the filter, mechanical device failure, and operator error.Some studies suggest that strenuous physical activity and increased intra-abdominal pressure can lead to the fracture and migration of ivc filters.Physiologic causes of migration may result from temporary dysmorphism of the inferior vena cava including bending, coughing or valsalva maneuvers resulting in dislodgment of the filter.Migration of ivc filters has been demonstrated when the presence of an overburden of thrombus in the vasculature occurs that exceeds the devices¿ ability to exert radial force toward the vessel walls and maintain optimal positioning and in patients who were in a dehydrated state when the filter was placed and have since re-hydrated thereby expanding the diameter of the vena cava.Based on the device history record review, there is no indication that the event is related to the device design or manufacturing process.Therefore, no preventative or corrective actions will be taken at this time.
 
Event or Problem Description
The device was not returned for evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTEASE
Common Device Name
FILTER, INTRAVASCULAR, CARDIOVASCULAR
Manufacturer (Section D)
CORDIS US CORP
14201 nw 60th avenue
miami lakes, florida 33014
Manufacturer (Section G)
CORDIS US CORP.
14201 nw 60 avenue
miami lakes, florida 33014
Manufacturer Contact
karla castro
santiago troncoso 808
juarez, chihuahua 
7863138372
MDR Report Key20956759
Report Number9616099-2024-00553
Device Sequence Number12025158
Product Code DTK
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K034050
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 02/07/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number466F210AF
Device Lot Number18356215
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/09/2024
Supplement Date Received by Manufacturer01/31/2025
Initial Report FDA Received Date12/17/2024
Supplement Report FDA Received Date02/07/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured07/31/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
UNK GUIDEWIRE, SNARE.
Patient SexUnknown
-
-